期刊文献+

成骨细胞中非核效应信号转导机制的研究进展 被引量:4

Research progress in signal transduction mechanisms of non-nuclear effects in osteoblasts
下载PDF
导出
摘要 雌激素缺乏是导致骨质疏松的重要原因之一。雌激素治疗骨质疏松症的临床疗效已获得普遍认可,其抗骨质疏松的作用,主要是通过促进成骨细胞增殖而产生效应。关于雌激素促成骨细胞的增殖,区别于经典的核效应,由雌激素膜受体介导的非核效应已成为研究热点。然而目前成骨细胞中非核效应的信号转导机制尚存争议。非核效应在成骨细胞中具体通过何种路径如ERK/MAPK通路、PI3K/Akt通路、Ca2+通路及新型雌激素受体GPER介导的信号通路产生效应尚无统一认识。故本文就目前已提出的非核效应信号转导途径学说及研究进展进行介绍。 Estrogen deficiency is one of the important causes of osteoporosis .The curative effect of estrogen in the clinical treatment of osteoporosis has won the general recognition .Its anti-osteoporosis effect is mainly through the effect on osteoblast proliferation .Different from the classic nuclear effects , non-nuclear effect mediated by estrogen receptor becomes the hot topics currently in the contribution of estrogen to osteoblast proliferation.However , the signal pathway mechanism of non-nuclear effect in osteoblast is still controversial . The signal pathways include ERK/MAPK pathway , PI3K/Akt pathway , Ca2+pathway and a novel estrogen receptor signaling pathway mediated by GPER .There is not unified understanding in which is the right signal pathway that make non-nuclear effect in osteoblasts .Thus this paper introduces the signal transduction theories of non-nuclear effects and the research progress in recent years .
作者 薛俊伟 尹宏
出处 《北京生物医学工程》 2015年第3期316-319,329,共5页 Beijing Biomedical Engineering
基金 江苏中医药管理局科学基金项目(Z13108)资助
关键词 成骨细胞 雌激素 膜受体 非核效应 信号转导 osteoblast estrogen membrane receptor non-nuclear effect signal transduction
  • 相关文献

参考文献31

  • 1Ba.czyk G, Opala T, Kleka P, et al. Muhifactorial analysis of risk factors for reduced bone mineral density among postmenopausal women[J]. Arch Med Sci, 2012,8(2) :332-341.
  • 2Hong L, Colpan A, Peptan IA. Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells[J]. Tissue Eng,2006, 12(10) :2747-2753.
  • 3Garmendia J, Phillips AD, Carlier MF, et al. TccP is an enterohaemorrhagic Escherichia eoli 0157:H7 type III effector protein that couples Tit to the actin-cytoskeleton [ J ]. Cell Microbiol, 2004, 6(12):1167-1183.
  • 4Santen R J, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an endocrine society scientific statement [J].J Clin Endocrinol Metab, 2010, 95(7 Suppl 1 ) :sl-s66.
  • 5Pietras RJ, Szego CM. Endometrial cell calcium and oestrogen action[J]. Nature,1975,253(5490) :357-359.
  • 6Pappas TC, Gametchu B, Watson CS. Membrane estrogen receptors identified by multiple antibody labeling and impeded- ligand binding [J]. FASEB J, 1995,9 ( 5 ) :404-410.
  • 7Bartell SM, Han L, Kim HN, et al. Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass [ J ]. Mol Endocrinol,2013,27 (4) :649-656.
  • 8Galeotti N, Ghelardini C. Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation [ J ]. Int J Neuropsychopharmacol,2012 , 15 (6) :781-793.
  • 9查锡良.生物化学[M].7 版.北京:人民卫生出版社,2010.
  • 10O' Mahony F, Razandi M, Pedram A, et al. Estrogen modulates metabolic pathway adaptation to available glucose in breast cancer ceils [ J ]. Mol Endocrinol,2012,26 (12) :2058-2070.

二级参考文献100

  • 1谭清武.骨质疏松症临床验方用药规律探析[J].中医研究,2004,17(3):2-3. 被引量:8
  • 2庄明明,温奕欣,刘少列,洪晓鹏.流式细胞仪测定血小板胞浆游离钙浓度[J].西安交通大学学报(医学版),2005,26(5):508-510. 被引量:4
  • 3迟晓星,崔洪斌.大豆异黄酮对妇女更年期综合征及骨密度的作用研究[J].中国骨质疏松杂志,2005,11(3):311-313. 被引量:23
  • 4任萍,季晖,陈秀英,韩景超,邵卿,濮祖茂.大豆苷元磺酸钠对维甲酸诱导大鼠骨质疏松的保护作用[J].中国骨质疏松杂志,2006,12(6):623-626. 被引量:9
  • 5Willson T M,Norris J D,Wagner B L,Asplin L,Baer P,Brown H R,et al. Dissection of the molecular mechanism of action of GW5638 ,a novel estrogen receptor ligand, provides insights in to the role of estrogen receptor in bone [J]. Endocrinology, 1997,138,3901-3911.
  • 6Miyamoto K, Kesterson R A, Yamamoto H, Taketani Y, Nishiwaki E,Tatsumi S, et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter[J]. Mol Endocrinol, 1997,11 : 1165 1179.
  • 7Bellido T, Girasole G, Passeri G, Yu X P, Mocharla H, Jilka R L,et al. Demonstration of estrogen and vitamin D receptors in bone marrow derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3 [J]. Endocrinology, 1993,133:553-562.
  • 8Schwartz B,Smirnoff P,Shany S, Liel Y. Estrogen controls expression and bioresponse of 1,25 dihydroxyvitamin D receptors in the rat colon[J]. Mol Cell Biochem, 2000,203: 87-93.
  • 9Studzinski G P, Wang X,Ji Y, Wang Q, Zhang Y, Kutner A, Harrison J B. The rationale for deltanoids in therapy for myeloid leukemia:role of KSR MAPK C/EBP pathway[J].J Steroid Biochem Mol giol, 2005,97 : 47 55.
  • 10Lai C F, Chaudhary L, Fausto A, Halstead L R, Ory D S, Avioli L V, et al. ERK is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells[J]. J Biol Chem,2001,276 : 14443 14450.

共引文献78

同被引文献35

  • 1韩盈,杨长春,郑静晨,李蓉,赵彦功,张菁.老年人代谢综合征临床特点及相关因素分析[J].中国健康教育,2007,23(6):444-446. 被引量:5
  • 2刘长锁,申竹芳.游离脂肪政与胰岛素抵抗[J].中国药理学通报,2005,21(2):145-9.
  • 3吴桂萍,车晓文,张虹,等.中老年代谢综合征患者认知功能障碍的特点[J].中国实用内科杂志,2009,29(S2):81-82.
  • 4Kuo CC,Lin CC,Tsai FM. Effectiveness of empowerment-based self -management interventions on patients withchronic metabolic diseases:a systematic review and meta-analyeis [J]. Worldviews Evid Based Nurs,2014,ll(5):301-315.
  • 5Summer R,Walsh K,Medoff BD. Obesity and pulmonaryarterialhypertension : is adiponectin the molecular link be-tween these conditions? [J]. Pulm Circ,2011,1(4) :440-447.
  • 6Burger CD,Foreman AJ,Miller DP,et al. Comparison ofbodyhabitus inpatients with pulmonary arterial hyperten-sion enrolled inthe registry to evaluate early and long-term PAH disease managementwith normative valuesfrom the national health and nutritionexamination survey [J|.Mayo Clin Proc ,2011,86(2) : 105-112.
  • 7Weng M , Raher MJ , Leyton P, et al. Adiponectin de-creases pulmonaryarterial remodeling in murine models6f pulmonary hypertension [J]. Am J Respir Cell Mol Bi-ol,2011,45(2) :340-347.
  • 8Hansmann G,Wagner RA,Schellong S,et al. Pulmonaryarterialhypertension is linked to insulin resistance andreversed by peroxisomeproliferator -activatedreceptor -gamma activation [J]. Circulation,2007,115( 10) : 1275-1284.
  • 9Martin E,Haney E,Shannon J,et al. Femoral volumetricbone density,geometry,and strength in relation to 25 -hydroxy vitamin d in older men [J], J Bone Miner Res,2015,30(3):475-482.
  • 10张健,赵斐,张勇.雌激素、运动与绝经后骨质疏松症[J].沈阳体育学院学报,2009,28(3):67-69. 被引量:14

引证文献4

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部